Semaglutide
Semaglutide is one of the most evidence-supported peptide therapies in medicine, approved for type 2 diabetes and obesity.
Peptide Database
Lysine-Proline-Valine (α-MSH 11-13)
Lysine-Proline-Valine (KPV) is a tripeptide fragment corresponding to residues 11-13 of the full-length α-melanocyte-stimulating hormone (α-MSH). α-MSH is a 13-amino acid neuropeptide derived from proopiomelanocortin…
Glycyl-L-Histidyl-L-Lysine-Copper Complex
Glycyl-L-Histidyl-L-Lysine-Copper Complex (GHK-Cu) is a naturally derived, copper-binding tripeptide that plays a significant role in tissue repair and remodeling. It was first identified in human…
Defensin
Defensins are a family of small, cationic, cysteine-rich antimicrobial peptides that constitute a critical component of the innate immune system in vertebrates, invertebrates, and plants.…
Gonadorelin
Gonadorelin is a synthetic decapeptide that is identical to the endogenous gonadotropin-releasing hormone (GnRH). It was first isolated and characterized from porcine and ovine hypothalami…
Retatrutide
A triple agonist (GLP-1 / GIP / glucagon) with weight-loss effect sizes that exceed even tirzepatide in Phase 2.
Thymalin
⊘ Insufficient evidence
Tirzepatide
Tirzepatide is the most effective approved weight-loss therapy currently in clinical practice.
Melanotan II
Melanotan-II has documented adverse events commonly under-disclosed. Not approved in any major market.
Hexarelin
An older non-selective growth hormone-releasing peptide (GHRP) with a real cortisol and prolactin elevation profile that worsens with chronic use.